利用多组学技术实现帕金森病生物标志物的发现：挑战、前景与未来。 - Suppr

Suppr

超能文献

Enabling biomarker discovery in Parkinson's disease using multiomics: challenges, promise and the future.

作者信息

Kiebish Michael A, Narain Niven R

机构信息

BERG LLC, Precision Medicine Division, Framingham, MA 01701, USA.

出版信息

Per Med. 2019 Jan;16(1):5-7. doi: 10.2217/pme-2018-0115. Epub 2018 Nov 13.

DOI:10.2217/pme-2018-0115

PMID:30422077

Abstract

摘要

相似文献

Enabling biomarker discovery in Parkinson's disease using multiomics: challenges, promise and the future.

Per Med. 2019 Jan;16(1):5-7. doi: 10.2217/pme-2018-0115. Epub 2018 Nov 13.

Translational Informatics for Parkinson's Disease: from Big Biomedical Data to Small Actionable Alterations.

Genomics Proteomics Bioinformatics. 2019 Aug;17(4):415-429. doi: 10.1016/j.gpb.2018.10.007. Epub 2019 Nov 28.

Interview with Mark Frasier: a Michael J Fox Foundation perspective on precision medicine in Parkinson's.

Per Med. 2017 Jan;14(1):13-15. doi: 10.2217/pme-2016-0087. Epub 2016 Nov 30.

Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1(Suppl 1):S15-S18. doi: 10.1016/j.parkreldis.2017.07.021. Epub 2017 Jul 22.

Personalized Medicine Approaches in Parkinson's Disease: The Genetic Perspective.

J Parkinsons Dis. 2016 Oct 19;6(4):699-701. doi: 10.3233/JPD-160876.

Parkinson's Disease in the Era of Personalised Medicine: One Size Does Not Fit All.

Drugs Aging. 2019 Feb;36(2):103-113. doi: 10.1007/s40266-018-0624-5.

Personalized medicine in Parkinson's disease: Time to be precise.

Mov Disord. 2017 Aug;32(8):1147-1154. doi: 10.1002/mds.27027. Epub 2017 Jun 12.

Biomarkers of Parkinson's disease: 20 years later.

J Neural Transm (Vienna). 2019 Jul;126(7):803-813. doi: 10.1007/s00702-019-02001-3. Epub 2019 Apr 4.

Biomarkers for Parkinson's disease.

Sci Transl Med. 2011 Apr 20;3(79):79ps14. doi: 10.1126/scitranslmed.3002488.

Nonmotor Parkinson's and Future Directions.

Int Rev Neurobiol. 2017;134:1493-1505. doi: 10.1016/bs.irn.2017.05.017. Epub 2017 Jul 4.

引用本文的文献

MoNET: an R package for multi-omic network analysis.

Bioinformatics. 2022 Jan 27;38(4):1165-1167. doi: 10.1093/bioinformatics/btab722.

Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics.

Metabolites. 2020 May 29;10(6):224. doi: 10.3390/metabo10060224.

DNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases.

Chromosome Res. 2019 Dec;27(4):345-364. doi: 10.1007/s10577-019-09617-x. Epub 2019 Nov 9.

The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis.

Neurol Sci. 2019 Dec;40(12):2479-2489. doi: 10.1007/s10072-019-04014-y. Epub 2019 Aug 7.

Unequivocal Biomarker for Parkinson's Disease: A Hunt that Remains a Pester.

Neurotox Res. 2019 Oct;36(3):627-644. doi: 10.1007/s12640-019-00080-4. Epub 2019 Jul 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Enabling biomarker discovery in Parkinson's disease using multiomics: challenges, promise and the future.

Per Med. 2019 Jan;16(1):5-7. doi: 10.2217/pme-2018-0115. Epub 2018 Nov 13.

Translational Informatics for Parkinson's Disease: from Big Biomedical Data to Small Actionable Alterations.

Genomics Proteomics Bioinformatics. 2019 Aug;17(4):415-429. doi: 10.1016/j.gpb.2018.10.007. Epub 2019 Nov 28.

Interview with Mark Frasier: a Michael J Fox Foundation perspective on precision medicine in Parkinson's.

Per Med. 2017 Jan;14(1):13-15. doi: 10.2217/pme-2016-0087. Epub 2016 Nov 30.

Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1(Suppl 1):S15-S18. doi: 10.1016/j.parkreldis.2017.07.021. Epub 2017 Jul 22.

Personalized Medicine Approaches in Parkinson's Disease: The Genetic Perspective.

J Parkinsons Dis. 2016 Oct 19;6(4):699-701. doi: 10.3233/JPD-160876.

Parkinson's Disease in the Era of Personalised Medicine: One Size Does Not Fit All.

Drugs Aging. 2019 Feb;36(2):103-113. doi: 10.1007/s40266-018-0624-5.

Personalized medicine in Parkinson's disease: Time to be precise.

Mov Disord. 2017 Aug;32(8):1147-1154. doi: 10.1002/mds.27027. Epub 2017 Jun 12.

Biomarkers of Parkinson's disease: 20 years later.

J Neural Transm (Vienna). 2019 Jul;126(7):803-813. doi: 10.1007/s00702-019-02001-3. Epub 2019 Apr 4.

Biomarkers for Parkinson's disease.

Sci Transl Med. 2011 Apr 20;3(79):79ps14. doi: 10.1126/scitranslmed.3002488.

Nonmotor Parkinson's and Future Directions.

Int Rev Neurobiol. 2017;134:1493-1505. doi: 10.1016/bs.irn.2017.05.017. Epub 2017 Jul 4.

引用本文的文献

MoNET: an R package for multi-omic network analysis.

Bioinformatics. 2022 Jan 27;38(4):1165-1167. doi: 10.1093/bioinformatics/btab722.

Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics.

Metabolites. 2020 May 29;10(6):224. doi: 10.3390/metabo10060224.

DNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases.

Chromosome Res. 2019 Dec;27(4):345-364. doi: 10.1007/s10577-019-09617-x. Epub 2019 Nov 9.

The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis.

Neurol Sci. 2019 Dec;40(12):2479-2489. doi: 10.1007/s10072-019-04014-y. Epub 2019 Aug 7.

Unequivocal Biomarker for Parkinson's Disease: A Hunt that Remains a Pester.

Neurotox Res. 2019 Oct;36(3):627-644. doi: 10.1007/s12640-019-00080-4. Epub 2019 Jul 2.